1. From the Clinical Proteomics Research Center (M.M.N., A.T.K., F.S.B., D.M., E.H.L.), Neuroprotection Research Laboratory (M.M.N., S.G., S.R.L., X.W., E.H.L.), Stroke/Neurocritical Care (M.M.N., F.S.B.), Massachusetts General Hospital, Harvard Medical School, Boston, Mass; Children's Hospital Boston (A.T.K.), CHIP, Boston, Mass; Harvard Partners Center for Genetics and Genomics (D.A.S., B.K.), Boston, Mass; EMBL (J.A.V., S.O.), European Bioinformatics Institute, Cambridge, UK.